Even though he is in stage 4, they have caught this in the early part of stage 4. The majority of the cancer is in his spleen and a few lymph nodes around the spleen and in the groin area. Doctors are very optimistic and are going to treat this very aggressively.
Dan will have a port installed into his chest next week. The doctors will harvest stem cells and then will start chemotherapy the following day. The chemotherapy will be 18 weeks. After chemo the doctors will take the stem cells that were harvested and replace them back into Dan.
This will be a difficult battle but if anyone can kick this, it is Dan. He will be off work for a portion of this therapy and hospital bills will add up quickly. To help Dan cover loss work, monthly bills and hospital bills I have set up this Go Fund Me page. If you know Dan, you know he is usually the first person to lend a hand or help someone in need. Please consider a donation. Know that your thoughts and prayers are greatly appreciated. If you are unable to donate please hug your family, tell them how much they mean to you. On behalf of Dan and the rest of the Pasker Family……Thank you!
Below is a little information regarding Mantle Cell Lymphoma:
Non-Hodgkin’s Mantle Cell Lymphoma is a relatively rare cancer of the lymphoid cells that arises from the outer rim or mantle lymphoid follicle. The disease is called "mantle cell lymphoma" because the tumor cells originally come from the "mantle zone" of the lymph node. MCL is usually diagnosed as a late-stage disease that has typically spread to the gastrointestinal tract and bone marrow. MCL is an aggressive B-cell type of non-Hodgkin's lymphoma and accounts for about 2%-10% of non-Hodgkin's lymphomas.
MCL occurs more frequently in older adults—the average age at diagnosis is the mid-60s. It is more often diagnosed in males than in females and white men and women are at a higher risk than black men and women for an MCL diagnosis.
There are four stages of MCL, but most patients (70%) are only diagnosed after they are in stage IV, the stage with the worst prognosis when MCL spreads to other organs.
MCL is treated with chemotherapy, radiotherapy, and combination methods and Stem Cell Transplantation. Because outcomes with conventional chemotherapy have been disappointing, autologous stem cell transplantation has been combined with initial first-line treatment of MCL. The purpose of autologous stem cell transplantation is to enhance the response to induction therapy and to prolong remission. In autologous stem cell transplantation, a patient’s own stem cells are collected and stored (harvested). The harvested cells are frozen and then returned to the patient after he or she has received intensive high-dose chemotherapy either with or without radiation therapy. High-dose chemotherapy with autologous stem cell transplantation has resulted in high rates of clinical remission for MCL patients when used in first complete remission and may be an option for clinically symptomatic fit younger patients with few or no coexisting illnesses. Autologous transplantation combined with effective induction agents, including combinations of monoclonal antibodies and chemotherapy, may offer a longer remission in these patients.
- Nancy Brannon
- Aide/Schumer Family
- Austin Copeland
- Erica Wiley
- God Bless
#1 fundraising platform
More people start fundraisers on GoFundMe than on any other platform. Learn more
Expert advice, 24/7
Contact us with your questions and we’ll answer, day or night. Learn more